Elizabeth L Christie

15PUBLICATIONS
186CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Sep 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer.

Carmelo Cerra, Madeleine R C Tancock, Niko Thio

|Jul 16, 2025
Genome doubling fuels ovarian cancer evolution and immune dysregulation.

Nikki L Burdett, Elizabeth L Christie

|Feb 19, 2025
Immunogenic cryptic peptides dominate the antigenic landscape of ovarian cancer.

Remya Raja, Kiran K Mangalaparthi, Anil K Madugundu

|Jul 18, 2024
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer.

Nikki L Burdett, Madelynne O Willis, Ahwan Pandey

Pageof 3